BNP Paribas Invests Broadly
BNP Paribas Financial Markets Significantly Expands Stakes in Multiple Key U.S. Stocks
BNP Paribas and its financial-markets arm boosted positions across a range of U.S.-listed stocks, including Wells Fargo, Western Midstream Partners, West Pharmaceutical Services, Smurfit Westrock, and Weyerhaeuser, according to recent filings. In Wells Fargo, BNP Paribas sharply increased its stake, while multiple other institutional investors also raised or adjusted their holdings, leaving a large majority of shares controlled by institutions and hedge funds. BNP Paribas Financial Markets also expanded its investment in Western Midstream Partners, where analysts cited by the report include Citigroup’s neutral stance with an increased price target and other coverage updates. For West Pharmaceutical Services and Smurfit Westrock, BNP Paribas Financial Markets likewise grew its stakes, with the latter accompanied by analyst commentary including a reduced price target from RBC alongside reaffirmed bullish views from other banks. In Weyerhaeuser, BNP Paribas Financial Markets added heavily, and the company’s balance sheet and trading metrics highlighted in the filing suggest a mature REIT profile with substantial institutional ownership. Overall, the articles portray a broad, multi-sector accumulation by BNP Paribas entities rather than a single-company bet, with other large funds and sell-side analysts remaining active as well.
Key Points
In Wells Fargo (WFC), besides BNP Paribas’ large add, the filing coverage listed several specific institutional changes: Private Wealth Group LLC raised its stake by 2.5%, Nixon Peabody Trust Co. by 3.6%, Simmons Bank by 1.9%, and Moss Adams Wealth Advisors by 1.0%, with 75.90% of WFC shares reported as owned by institutional investors and hedge funds.
For West Pharmaceutical Services (WST), the report included an insider transaction: Chief Accounting Officer Chad Winters sold 896 shares on April 27 at an average price of $300.67 (a 37.04% decrease in his ownership), according to the SEC filing described in the article.
For Smurfit Westrock (SW), analyst coverage cited additional banks beyond RBC: Royal Bank of Canada cut its price target from $54 to $53 while keeping an “outperform” rating; Morgan Stanley reiterated an “overweight” rating with a $57 price target; and JPMorgan Chase & Co. was also cited as lowering its target price (the article reports the change but truncates the exact prior/new figures).
For Weyerhaeuser (WY), the article highlighted other major institutional activity and company valuation/trading metrics: Norges Bank opened a new position worth about $549,531,000, and Weyerhaeuser’s reported stats included a $17.56 billion market cap, PE ratio of 45.10, beta of 0.89, and a debt-to-equity ratio of 0.54 (with institutional investors owning 82.99% of shares).
Sentiment
Mostly PositivePublishers
31
Articles
22
Reach
53
